Facile synthesis of magnetic–plasmonic nanocomposites as T 1 MRI contrast enhancing and photothermal therapeutic agents

Nano Research

Volumn 9, Issue 3, 2016, Pages 787-799

  Yang, Zhongzhen ^a,b   Ding, Xianguang ^a,b   Jiang, Jiang ^a  

^a SUZHOU INSTITUTE OF NANO TECH AND NANO BIONICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

iron oxide; magnetic resonance imaging (MRI); photothermal; plasmonics; T1; theranostics

Indexed keywords

COREMAKING; GOLD; GOLD COMPOUNDS; INFRARED DEVICES; INFRARED IMAGING; IRON OXIDES; MAGNETISM; NANOCOMPOSITES; NANORODS; PLASMONICS; PLASMONS; POLYPYRROLES;

CONTRAST-ENHANCING AGENTS; INFRARED THERMAL IMAGING; IRON OXIDE NANOPARTICLE; MAGNETIC RESONANCE IMAGING (MRI); PHOTO-THERMAL; PHOTOTHERMAL CONVERSION EFFICIENCIES; THERANOSTICS; THERAPEUTIC APPLICATION;

MAGNETIC RESONANCE IMAGING;

EID: 84959495864     PISSN: 19980124     EISSN: 19980000     Source Type: Journal    
DOI: 10.1007/s12274-015-0958-9     Document Type: Article

References (64)

1. 4 Core@hybrid@Au shell nanocomposite for bimodal imaging and photothermal therapy. Adv. Mater.2011, 23, 5392–5397.
2. 4 nanoparticles for target-specific platin delivery. J. Am. Chem. Soc.2009, 131, 4216–4217.
3. Bardhan, R.; Chen, W. X.; Bartels, M.; Perez-Torres, C.; Botero, M. F.; McAninch, R. W.; Contreras, A.; Schiff, R.; Pautler, R. G.; Halas, N. J. et al. Tracking of multimodal therapeutic nanocomplexes targeting breast cancer in vivo. Nano Lett.2010, 10, 4920–4928.
4. Lal, S.; Clare, S. E.; Halas, N. J. Nanoshell-enabled photothermal cancer therapy: Impending clinical impact. Acc. Chem. Res.2008, 41, 1842–1851.
5. 4 nanoparticle “nano-pearl-necklaces” for simultaneous targeting, dual-mode imaging, and photothermal ablation of cancer cells. Angew. Chem., Int. Ed.2009, 48, 2759–2763.
6. Liong, M.; Lu, J.; Kovochich, M.; Xia, T.; Ruehm, S. G.; Nel, A. E.; Tamanoi, F.; Zink, J. I. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano2008, 2, 889–896.
7. Larson, T. A.; Bankson, J.; Aaron, J.; Sokolov, K. Hybrid plasmonic magnetic nanoparticles as molecular specific agents for MRI/optical imaging and photothermal therapy of cancer cells. Nanotechnology2007, 18, 325101.
8. Ma, L. L.; Feldman, M. D.; Tam, J. M.; Paranjape, A. S.; Cheruku, K. K.; Larson, T. A.; Tam, J. O.; Ingram, D. R.; Paramita, V.; Villard, J. W. et al. Small multifunctional nanoclusters (nanoroses) for targeted cellular imaging and therapy. ACS Nano2009, 3, 2686–2696.
9. El-Sayed, I. H.; Huang, X. H.; El-Sayed, M. A. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: Applications in oral cancer. Nano Lett.2005, 5, 829–834.
10. Wu, X.; Ming, T.; Wang, X.; Wang, P. N.; Wang, J. F.; Chen, J. Y. High-photoluminescence-yield gold nanocubes: For cell imaging and photothermal therapy. ACS Nano2010, 4, 113–120.
11. Novo, C.; Funston, A. M.; Pastoriza-Santos, I.; Liz-Marzán, L. M.; Mulvaney, P. Spectroscopy and high-resolution microscopy of single nanocrystals by a focused ion beam registration method. Angew. Chem., Int. Ed.2007, 46, 3517–3520.
12. Kennedy, L. C.; Bickford, L. R.; Lewinski, N. A.; Coughlin, A. J.; Hu, Y.; Day, E. S.; West, J. L.; Drezek, R. A. A new era for cancer treatment: Gold-nanoparticle-mediated thermal therapies. Small2011, 7, 169–183.
13. Chen, J. Y.; Glaus, C.; Laforest, R.; Zhang, Q.; Yang, M. X.; Gidding, M.; Welch, M. J.; Xia, Y. N. Gold nanocages as photothermal transducers for cancer treatment. Small2010, 6, 811–817.
14. Hirsch, L. R.; Stafford, R. J.; Bankson, J. A.; Sershen, S. R.; Rivera, B.; Price, R. E.; Hazle, J. D.; Halas, N. J.; West, J. L. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. USA2003, 100, 13549–13554.
15. Weissleder, R.; Pittet, M. J. Imaging in the era of molecular oncology. Nature2008, 452, 580–589.
16. 1 MRI contrast agents. J. Mater. Chem.2009, 19, 6267–6273.
17. Na, H. B.; Song, I. C.; Hyeon, T. Inorganic nanoparticles for MRI contrast agents. Adv. Mater.2009, 21, 2133–2148.
18. Jun, Y. W.; Huh, Y. M.; Choi, J. S.; Lee, J. H.; Song, H. T.; Kim, S.; Yoon, S.; Kim, K. S.; Shin, J. S.; Suh, J. S. et al. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J. Am. Chem. Soc.2005, 127, 5732–5733.
19. Jun, Y.-W.; Seo, J.-W.; Cheon, A. Nanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciences. Acc. Chem. Res.2008, 41, 179–189.
20. Huh, Y. M.; Jun, Y. W.; Song, H. T.; Kim, S.; Choi, J. S.; Lee, J. H.; Yoon, S.; Kim, K. S.; Shin, J. S.; Suh, J. S. et al. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J. Am. Chem. Soc.2005, 127, 12387–12391.
21. Gao, J. H.; Liang, G. L.; Cheung, J. S.; Pan, Y.; Kuang, Y.; Zhao, F.; Zhang, B.; Zhang, X. X.; Wu, E. X.; Xu, B. Multifunctional yolk–shell nanoparticles: A potential MRI contrast and anticancer agent. J. Am. Chem. Soc.2008, 130, 11828–11833.
22. Lee, N.; Kim, H.; Choi, S. H.; Park, M.; Kim, D.; Kim, H.-C.; Choi, Y.; Lin, S.; Kim, B. H.; Jung, H. S. et al. Magnetosome-like ferrimagnetic iron oxide nanocubes for highly sensitive MRI of single cells and transplanted pancreatic islets. Proc. Natl. Acad. Sci. USA2011, 108, 2662–2667.
23. Caravan, P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem. Soc. Rev.2006, 35, 512–523.
24. Hifumi, H.; Yamaoka, S.; Tanimoto, A.; Citterio, D.; Suzuki, K. Gadolinium-based hybrid nanoparticles as a positive MRcontrast agent. J. Am. Chem. Soc.2006, 128, 15090–15091.
25. 1 magnetic resonance imaging contrast agent. Adv. Mater.2009, 21, 4467–4471.
26. Bridot, J.-L.; Faure, A.-C.; Laurent, S.; Rivière, C.; Billotey, C.; Hiba, B.; Janier, M.; Josserand, V.; Coll, J.-L.; Vander Elst, L. et al. Hybrid gadolinium oxide nanoparticles: Multimodal contrast agents for in vivo imaging. J. Am. Chem. Soc.2007, 129, 5076–5084.
27. Rieter, W. J.; Kim, J. S.; Taylor, K. M. L.; An, H.; Lin, W. L.; Tarrant, T.; Lin, W. B. Hybrid silica nanoparticles for multimodal imaging. Angew. Chem., Int. Ed.2007, 46, 3680–3682.
28. 1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew. Chem., Int. Ed.2007, 46, 5397–5401.
29. Choi, S.-H.; Na, H. B.; Park, Y. I.; An, K.; Kwon, S. G.; Jang, Y.; Park, M.-H.; Moon, J.; Son, J. S.; Song, I. C. et al. Simple and generalized synthesis of oxide-metal heterostructured nanoparticles and their applications in multimodal biomedical probes. J. Am. Chem. Soc.2008, 130, 15573–15580.
30. An, K.; Kwon, S. G.; Park, M.; Na, H. B.; Baik, S.-I.; Yu, J. H.; Kim, D.; Son, J. S.; Kim, Y. W.; Song, I. C. et al. Synthesis of uniform hollow oxide nanoparticles through nanoscale acid etching. Nano Lett.2008, 8, 4252–4258.
31. Yang, H.; Zhuang, Y. M.; Hu, H.; Du, X. X.; Zhang, C. X.; Shi, X. Y.; Wu, H. X.; Yang, S. P. Silica-coated manganese oxide nanoparticles as a platform for targeted magnetic resonance and fluorescence imaging of cancer cells. Adv. Funct. Mater.2010, 20, 1733–1741.
32. 1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells. J. Am. Chem. Soc.2011, 133, 2955–2961.
33. Penfield, J. G.; Reilly, R. F., What nephrologists need to know about gadolinium. Nat. Clin. Pract. Nephrol.2007, 3, 654–668.
34. Limbach, L. K.; Wick, P.; Manser, P.; Grass, R. N.; Bruinink, A.; Stark, W. J. Exposure of engineered nanoparticles to human lung epithelial cells: Influence of chemical composition and catalytic activity on oxidative stress. Environ. Sci. Technol.2007, 41, 4158–4163.
35. Bardhan, R.; Chen, W. X.; Perez-Torres, C.; Bartels, M.; Huschka, R. M.; Zhao, L. L.; Morosan, E.; Pautler, R. G.; Joshi, A.; Halas, N. J. Nanoshells with targeted simultaneous enhancement of magnetic and optical imaging and photothermal therapeutic response. Adv. Funct. Mater.2009, 19, 3901–3909.
36. Kim, J.; Park, S.; Lee, J. E.; Jin, S. M.; Lee, J. H.; Lee, I. S.; Yang, I.; Kim, J.-S.; Kim, S. K.; Cho, M.-H. et al. Designed fabrication of multifunctional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy. Angew. Chem., Int. Ed.2006, 45, 7754–7758.
37. Wang, L. Y.; Bai, J. W.; Li, Y. J.; Huang, Y. Multifunctional nanoparticles displaying magnetization and near-IR absorption. Angew. Chem., Int. Ed.2008, 47, 2439–2442.
38. Melancon, M. P.; Lu, W.; Zhong, M.; Zhou, M.; Liang, G.; Elliott, A. M.; Hazle, J. D.; Myers, J. N.; Li, C.; Stafford, R. J. Targeted multifunctional gold-based nanoshells for magnetic resonance-guided laser ablation of head and neck cancer. Biomaterials2011, 32, 7600–7608.
39. Ji, X.; Shao, R.; Elliott, A. M.; Stafford, R. J.; Esparza-Coss, E.; Bankson, J. A.; Liang, G.; Luo, Z.-P.; Park, K.; Markert, J. T. et al. Bifunctional gold nanoshells with a superparamagnetic iron oxide-silica core suitable for both MRimaging and photothermal therapy. J. Phys. Chem. C2007, 111, 6245–6251.
40. 2-xS core–shell nanoparticles for dualmodal imaging and photothermal therapy. J. Am. Chem. Soc.2013, 135, 8571–8577.
41. Roch, A.; Muller, R. N.; Gillis, P. Theory of proton relaxation induced by superparamagnetic particles. J. Chem. Phys.1999, 110, 5403–5411.
42. 1 magnetic resonance imaging contrast agents for molecular imaging. Langmuir2007, 23, 4583–4588.
43. 1 MR contrast agent based on ultrasmall PEGylated iron oxide nanoparticles. Nano Lett.2009, 9, 4434–4440.
44. Hu, F. Q.; MacRenaris, K. W.; Waters, E. A.; Liang, T. Y.; Schultz-Sikma, E. A.; Eckermann, A. L.; Meade, T. J. Ultrasmall, water-soluble magnetite nanoparticles with high relaxivity for magnetic resonance imaging. J. Phys. Chem. C2009, 113, 20855–20860.
45. 4 nanoparticles for potential bio-application. Nanoscale2013, 5, 2133–2141.
46. Ye, X. C.; Zheng, C.; Chen, J.; Gao, Y. Z.; Murray, C. B. Using binary surfactant mixtures to simultaneously improve the dimensional tunability and monodispersity in the seeded growth of gold nanorods. Nano Lett.2013, 13, 765–771.
47. Frens, G. Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nat. Phys. Sci.1973, 241, 20–22.
48. Li, J.; Wu, J.; Zhang, X.; Liu, Y.; Zhou, D.; Sun, H. Z.; Zhang, H.; Yang, B. Controllable synthesis of stable urchin-like gold nanoparticles using hydroquinone to tune the reactivity of gold chloride. J. Phys. Chem. C2011, 115, 3630–3637.
49. Chen, L.; Ji, F.; Xu, Y.; He, L.; Mi, Y. F.; Bao, F.; Sun, B. Q.; Zhang, X. H.; Zhang, Q. High-yield seedless synthesis of triangular gold nanoplates through oxidative etching. Nano Lett.2014, 14, 7201–7206.
50. 2-xSe nanocrystals with tunable localized surface plasmon resonance and enhanced chemiluminescence. Nanoscale2014, 6, 10289–10296.
51. Xing, S. X.; Tan, L. H.; Yang, M. X.; Pan, M.; Lv, Y. B.; Tang, Q. H.; Yang, Y. H.; Chen, H. Y. Highly controlled core/shell structures: Tunable conductive polymer shells on gold nanoparticles and nanochains. J. Mater. Chem.2009, 19, 3286–3291.
52. Lin, M.; Guo, C. R.; Li, J.; Zhou, D.; Liu, K.; Zhang, X.; Xu, T. S.; Zhang, H.; Wang, L. P.; Yang, B. Polypyrrolecoated chainlike gold nanoparticle architectures with the 808 nm photothermal transduction efficiency up to 70%. ACS Appl. Mater. Interfaces2014, 6, 5860–5868.
53. Liu, Z. M.; Ye, B. G.; Jin, M.; Chen, H. L.; Zhong, H. Q.; Wang, X. P.; Guo, Z. Y. Dye-free near-infrared surfaceenhanced Raman scattering nanoprobes for bioimaging and high-performance photothermal cancer therapy. Nanoscale2015, 7, 6754–6761.
54. Zha, Z. B.; Yue, X. L.; Ren, Q. S.; Dai, Z. F. Uniform polypyrrole nanoparticles with high photothermal conversion efficiency for photothermal ablation of cancer cells. Adv. Mater.2013, 25, 777–782.
55. Wang, Q.; Wang, J. D.; Lv, G.; Wang, F.; Zhou, X. K.; Hu, J. Q.; Wang, Q. G. Facile synthesis of hydrophilic polypyrrole nanoparticles for photothermal cancer therapy. J. Mater. Sci.2014, 49, 3484–3490.
56. Hong, J.-Y.; Yoon, H.; Jang, J. Kinetic study of the formation of polypyrrole nanoparticles in water-soluble polymer/metal cation systems: A light-scattering analysis. Small2010, 6, 679–686.
57. 4 nanocomposites for MR/CT dual-modal imaging guided-photothermal therapy: An in vitro study. ACS Appl. Mater. Interfaces2015, 7, 4354–4367.
58. 4 nanoparticles for dual-modal imaging and in vivo photothermal cancer therapy. Small2014, 10, 1063–1068.
59. Vaitkuviene, A.; Kaseta, V.; Voronovic, J.; Ramanauskaite, G.; Biziuleviciene, G.; Ramanaviciene, A.; Ramanavicius, A. Evaluation of cytotoxicity of polypyrrole nanoparticles synthesized by oxidative polymerization. J. Hazard. Mater.2013, 250-251, 167–174.
60. Stewart, E. M.; Liu, X.; Clark, G. M.; Kapsa, R. M. I.; Wallace, G. G. Inhibition of smooth muscle cell adhesion and proliferation on heparin-doped polypyrrole. Acta Biomater.2012, 8, 194–200.
61. Ramanaviciene, A.; Kausaite, A.; Tautkus, S.; Ramanavicius, A. Biocompatibility of polypyrrole particles: An in-vivo study in mice. J. Pharm. Pharmacol.2007, 59, 311–315.
62. 1 MRI contrast agent. J. Am. Chem. Soc.2013, 135, 18621–18628.
63. Roper, D. K.; Ahn, W.; Hoepfner, M. Microscale heat transfer transduced by surface plasmon resonant gold nanoparticles. J. Phys. Chem. C2007, 111, 3636–3641.
64. Ding, X. G.; Liow, C. H.; Zhang, M. X.; Huang, R. J.; Li, C. Y.; Shen, H.; Liu, M. Y.; Zou, Y.; Gao, N.; Zhang, Z. J. et al. Surface plasmon resonance enhanced light absorption and photothermal therapy in the second near-infrared window. J. Am. Chem. Soc.2014, 136, 15684–15693.